Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD
19.38
+0.47 (2.49%)
At close: Mar 27, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
Biologic Therapies for Autoimmune and Allergic Diseases | 158.79M | - | 9.66M | 21.35M |
Biologic Therapies for Autoimmune and Allergic Diseases Growth | - | - | -54.74% | - |
| 158.79M | - | 9.66M | 21.35M |
| - | - | -54.74% | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 158.79M | - | 9.66M | 21.35M |
| - | - | -54.74% | - |
| 158.79M | - | 9.66M | 21.35M |
| - | - | -54.74% | - |
Source: S&P Global Market Intelligence.
